AFFX Affymetrix, Inc.

Affymetrix to Webcast Presentation at the Nasdaq 15th Investor Program Healthcare Forum SANTA CLARA, Calif., May 12 /PRNewswire-FirstCall/ -- Affymetrix, Inc. (NASDAQ:AFFX) today announced that Greg Schiffman, Executive Vice President and CFO, will provide a company overview at the Nasdaq 15th Investor Program Healthcare Forum at the Chancery Court Hotel in London. A live transmission of the presentation will take place at 10:45 a.m. BDT (5:45 a.m. EDT) on Thursday May 19, 2005. An archived webcast will be available for 30 days. To access the live webcast or archived presentation, find the "Investors" link in the "Resources for" drop-down menu on http://www.affymetrix.com/. About Affymetrix Affymetrix scientists invented the world's first microarray in 1989 and began selling the first commercial microarray in 1994. Since then, Affymetrix GeneChip(R) technology has become the industry standard in molecular biology research. Affymetrix technology is used by the world's top pharmaceutical, diagnostic and biotechnology companies as well as leading academic, government and not-for-profit research institutes. More than 1,200 systems have been shipped around the world and more than 3,000 peer-reviewed papers have been published using the technology. Affymetrix' patented photolithographic manufacturing process provides the most information capacity available today on an array, enabling researchers to use a whole-genome approach to analyze the relationship between genetics and health. Headquartered in Santa Clara, California, Affymetrix has subsidiaries in Europe and Asia in addition to manufacturing facilities in Sacramento, California and Bedford, Massachusetts. The Company has about 900 employees worldwide. DATASOURCE: Affymetrix, Inc. CONTACT: Doug Farrell, Vice President of Investor Relations of Affymetrix, Inc., +1-408-731-5285 Web site: http://www.affymetrix.com/

Copyright